Japan· JP-2229006F1030
クロペラスチンフェンジゾ酸塩
A cloperastine product containing クロペラスチンフェンジゾ酸塩, registered in Japan by ニプロ, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Cloperastine is registered in 3 of 19 countries.
Countries holding a registration under ATC R05DB21 (cloperastine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Cloperastine · ATC R05DB21
3 / 19 countries
- Belgiumprice
- Japan
- Spainprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- クロペラスチンフェンジゾ酸塩
- Manufacturer
- ニプロ
- Country
- Japan (JP)
- ATC code
- R05DB21
- ATC class
- Cloperastine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cloperastine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Lysotossil, Sekin
- Spain · Flutox
- Italy · Seki
- Luxembourg · Lysotossil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e629f3e6-0c03-440b-93db-55f10014a74f GET /v1/drugs/e629f3e6-0c03-440b-93db-55f10014a74f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２．５ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2229006F1030",
"category": "内用薬",
"price_yen": 10.8,
"generic_name": "クロペラスチンフェンジゾ酸塩",
"product_name_jp": null,
"therapeutic_class": "2229",
"transitional_expiry": null
}See everything about cloperastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.